BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15789227)

  • 1. Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab.
    Vallet S; Tempescul A; Tran A; Legrand-Quillien MC; Narbonne V; Berthou C
    Ann Hematol; 2005 Aug; 84(8):545-7. PubMed ID: 15789227
    [No Abstract]   [Full Text] [Related]  

  • 2. Late-onset neutropenia following viral bone marrow depression after rituximab therapy.
    Christopeit M; Haak U; Behre G
    Ann Hematol; 2008 Sep; 87(9):761-2. PubMed ID: 18350295
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphoma.
    Bauwens D; Maerevoet M; Michaux L; Théate I; Hagemeijer A; Stul M; Danse E; Costantini S; Vannuffel P; Straetmans N; Vekemans MC; Deneys V; Ferrant A; Van Den Neste E
    Br J Haematol; 2005 Nov; 131(3):338-40. PubMed ID: 16225653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
    Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
    Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab.
    Rey J; Belmecheri N; Bouayed N; Ivanov V; Coso D; Gastaut JA; Bouabdallah R
    Haematologica; 2007 Oct; 92(10):e101. PubMed ID: 18024364
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
    Robinson KS; Williams ME; van der Jagt RH; Cohen P; Herst JA; Tulpule A; Schwartzberg LS; Lemieux B; Cheson BD
    J Clin Oncol; 2008 Sep; 26(27):4473-9. PubMed ID: 18626004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.
    Rummel MJ; Al-Batran SE; Kim SZ; Welslau M; Hecker R; Kofahl-Krause D; Josten KM; Dürk H; Rost A; Neise M; von Grünhagen U; Chow KU; Hansmann ML; Hoelzer D; Mitrou PS
    J Clin Oncol; 2005 May; 23(15):3383-9. PubMed ID: 15908650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of focal segmental glomerulosclerosis in association with mantle cell lymphoma.
    Wong CF; Mohteshamzadeh M; Arsalanizadeh B; Dutt T; Shawki H; Khine MM; Rustom R
    Ren Fail; 2007; 29(3):363-6. PubMed ID: 17497453
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recommendation for the optimal use of bendamustine in Japan].
    Ohmachi K; Maruyama D; Nisikori M; Suzuki T; Izutsu K
    Rinsho Ketsueki; 2014 Mar; 55(3):311-20. PubMed ID: 24681934
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
    Magni M; Di Nicola M; Carlo-Stella C; Matteucci P; Devizzi L; Tarella C; Benedetti F; Martelli M; Patti C; Parvis G; Rambaldi A; Barbui T; Gianni AM
    Bone Marrow Transplant; 2009 Mar; 43(6):509-11. PubMed ID: 18955979
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the combination of rituximab and thalidomide influence the long-term perspectives of advanced-stage MCL?
    Lenz G; Dreyling M
    Nat Clin Pract Oncol; 2005 Feb; 2(2):72-3. PubMed ID: 16264875
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
    Ram R; Bonstein L; Gafter-Gvili A; Ben-Bassat I; Shpilberg O; Raanani P
    Am J Hematol; 2009 Apr; 84(4):247-50. PubMed ID: 19260124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New data prove therapeutic superiority. MabThera in follicular and mantle cell lymphoma].
    Krankenpfl J; 2002; 40(5-6):161. PubMed ID: 12271501
    [No Abstract]   [Full Text] [Related]  

  • 14. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
    Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF
    J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma.
    Arai Y; Tadokoro J; Mitani K
    Am J Hematol; 2005 Apr; 78(4):317-8. PubMed ID: 15795913
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma.
    de Guibert S; Jaccard A; Bernard M; Turlure P; Bordessoule D; Lamy T
    Haematologica; 2006 Mar; 91(3):425-6. PubMed ID: 16531272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
    Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA
    J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
    Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ
    Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients.
    van 't Veer MB; de Jong D; MacKenzie M; Kluin-Nelemans HC; van Oers MH; Zijlstra J; Hagenbeek A; van Putten WL
    Br J Haematol; 2009 Feb; 144(4):524-30. PubMed ID: 19036081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin's lymphoma.
    Nomura K; Kamitsuji Y; Kono E; Matsumoto Y; Yoshida N; Konishi H; Horiike S; Okanoue T; Taniwaki M
    Scand J Gastroenterol; 2005 May; 40(5):604-6. PubMed ID: 16036515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.